2026 Global: Non-Invasive Blood Glucose Monitoring Devices Market -Competitive Review (2032) report
Description
The 2026 Global: Non-Invasive Blood Glucose Monitoring Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The Non-Invasive Blood Glucose Monitoring Devices Market features leading companies advancing sensor-based, optical, and radiofrequency technologies to enable continuous glucose tracking without skin penetration. Top players include Abbott Laboratories, headquartered in Abbott Park, Illinois, USA, with its FreeStyle Libre CGM platform dominating through real-time insights and over-the-counter options. Dexcom, based in San Diego, California, USA, leads with G6 and G7 systems offering fingerstick-free monitoring via integrated apps. Medtronic, headquartered in Dublin, Ireland, integrates Guardian CGM sensors with MiniMed pumps for automated delivery. F. Hoffmann-La Roche Ltd., located in Basel, Switzerland, strengthens its position with Accu-Chek systems and broad distribution. Senseonics, in Germantown, Maryland, USA, provides implantable Eversense CGM with long-term wear.
Other key firms drive innovation in emerging non-invasive modalities. Nemaura Medical, headquartered in Loughborough, United Kingdom (inferred from typical operations), develops patch-based sugarBEAT for needle-free monitoring. Know Labs Inc., based in Seattle, Washington, USA, pioneers radiofrequency dielectric spectroscopy for the KnowU wearable. DiaMonTech GmbH, located in Berlin, Germany, advances laser-based quantum cascade technology for wearable devices. GlucoTrack (Integrity Applications), headquartered in Ashkelon, Israel, offers ultrasonic and thermal sensor clips for calibration-free readings. Masimo Corporation, in Irvine, California, USA, leverages pulse oximetry derivatives for non-invasive glucose estimation.
These companies collectively hold significant market share, with Abbott, Dexcom, and Medtronic accounting for over 55% in related glucose monitoring segments, fueled by R&D in AI calibration and wearables. Startups like Biolinq Inc. (San Diego, USA) and Afon Technology (Cambridge, UK) add competition through microneedle-free patches and radiofrequency wearables, targeting type 2 diabetes expansion. Global presence spans North America, Europe, and Asia, with firms like Sinocare in Changsha, China, providing cost-effective alternatives. Challenges include regulatory hurdles and accuracy validation, yet advancements promise broader accessibility by 2030.
The Non-Invasive Blood Glucose Monitoring Devices Market features leading companies advancing sensor-based, optical, and radiofrequency technologies to enable continuous glucose tracking without skin penetration. Top players include Abbott Laboratories, headquartered in Abbott Park, Illinois, USA, with its FreeStyle Libre CGM platform dominating through real-time insights and over-the-counter options. Dexcom, based in San Diego, California, USA, leads with G6 and G7 systems offering fingerstick-free monitoring via integrated apps. Medtronic, headquartered in Dublin, Ireland, integrates Guardian CGM sensors with MiniMed pumps for automated delivery. F. Hoffmann-La Roche Ltd., located in Basel, Switzerland, strengthens its position with Accu-Chek systems and broad distribution. Senseonics, in Germantown, Maryland, USA, provides implantable Eversense CGM with long-term wear.
Other key firms drive innovation in emerging non-invasive modalities. Nemaura Medical, headquartered in Loughborough, United Kingdom (inferred from typical operations), develops patch-based sugarBEAT for needle-free monitoring. Know Labs Inc., based in Seattle, Washington, USA, pioneers radiofrequency dielectric spectroscopy for the KnowU wearable. DiaMonTech GmbH, located in Berlin, Germany, advances laser-based quantum cascade technology for wearable devices. GlucoTrack (Integrity Applications), headquartered in Ashkelon, Israel, offers ultrasonic and thermal sensor clips for calibration-free readings. Masimo Corporation, in Irvine, California, USA, leverages pulse oximetry derivatives for non-invasive glucose estimation.
These companies collectively hold significant market share, with Abbott, Dexcom, and Medtronic accounting for over 55% in related glucose monitoring segments, fueled by R&D in AI calibration and wearables. Startups like Biolinq Inc. (San Diego, USA) and Afon Technology (Cambridge, UK) add competition through microneedle-free patches and radiofrequency wearables, targeting type 2 diabetes expansion. Global presence spans North America, Europe, and Asia, with firms like Sinocare in Changsha, China, providing cost-effective alternatives. Challenges include regulatory hurdles and accuracy validation, yet advancements promise broader accessibility by 2030.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



